Sirrus Corp. to Provide Penetration Test and Complete Vulnerability Assessment to Leading Healthcare Data Analytics Company

by Jessica Yaniv | April 30, 2018 1:45 pm

JOHNS CREEK, GA, May 01, 2018 (GLOBE NEWSWIRE) — Sirrus Corp. (“Sirrus” or the “Company”) (OTC PINK: SRUP), an emerging cybersecurity solutions provider, is pleased to announce that the Company has entered into a scope of services agreement to provide penetration test and vulnerability assessment (the “Agreement”) to a leading data analytics company in the healthcare sector (the “Client”).  Due to certain data privacy and security provisions for safeguarding medical information under the Health Insurance Portability and Accountability Act of 1996 (“HIPPA”), the name and geographic location of the Client must remain confidential.  

Penetration testing is the practice of examining a computer system, network, or application to identify security vulnerabilities that a potential hacker could exploit to gain access to critical and confidential data.  To accomplish this, Sirrus engineers take a customized approach utilizing various manual and automated attack vectors similar to that of experienced hackers attempting to exploit system vulnerabilities.

The Company anticipates that the penetration testing will focus on the three main areas most commonly exploited by hackers: architectural weaknesses and configuration vulnerabilities, code-level and design-level software vulnerabilities, and social engineering vulnerabilities like email and phone based phishing scams.  Sirrus’s penetration testing and social engineering assessment methodology are aligned with NIST SP800-115 and the Penetration Testing Execution Standard (PTES).

Following the completion of testing, Sirrus will prepare and present all key findings from assessment to the client, including a comprehensive Risk Ranked Assessment Report, Executive Summary Report, Technical Client Risk Report, and a Mitigation and Recommendations Report.

Sparrow Marcioni, Sirrus Corp. CEO, commented, “Penetration testing is at the very core of our security business and our expert team is among the very best at identifying security weaknesses in any system.  The fact that such a large technologically sophisticated healthcare data company that handles so many medical records has selected us to provide such a critically important service for them is a huge vote of confidence in support of our talent, expertise, and professionalism.  We look forward to completing this project on time and leveraging its success into additional potential projects.”

The Company is also currently in discussions with several other potential customers and anticipates completing one or more additional scope of services agreements to provide penetration testing in the near future.   

Additional information regarding Sirrus Corp. and Sirrus Security can be found at www.sirrussecurity.com[1].

About Sirrus Corp.

Sirrus Corp. (OTC PINK: SRUP) provides security technology products and services to assist companies with protecting their assets and information.  The Company is primarily focused on providing cybersecurity services to healthcare companies in the United States, which are required to be in compliance with government regulations such as the Health Insurance Portability and Accountability Act (“HIPAA”).

Cautionary Note Regarding Forward-Looking Statements

This press release by Sirrus Corp. (“Sirrus”) may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by words such as expects,” “plan,” “believes,” “will,” “achieve,” “anticipate,” “would,” “should,” “subject to,” or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Although Sirrus management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct.  These forward-looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated.  Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all.  Known risks and uncertainties include those identified from time to time in the reports filed by Sirrus Corp. with the SEC.  Sirrus assumes no obligation to update publicly any forward-looking statements contained in this press release.

CONTACT: Sirrus Corp. - Investor Relations:

Toll-Free: (888) 263-7622
E-mail: [email protected]
Website: www.sirrussecurity.com
Endnotes:
  1. www.sirrussecurity.com: https://www.globenewswire.com/Tracker?data=bJlAbUy2r0Obq6FeToKI1bi4jOeYd9oftj8kVvcGSROBeSeR9_SQdAtYTDaYaqAUi9hqLacOIx7NTmMC-APIOtjT91kEH55ZrDVvE7lRaaM=

Source URL: https://trustednerd.com/2018/04/30/sirrus-corp-to-provide-penetration-test-and-complete-vulnerability-assessment-to-leading-healthcare-data-analytics-company/